1.
Jemal A,
Bray F,
Center MM,
Ferlay J,
Ward E,
Forman D.
Global cancer statistics.
CA Cancer J Clin.
2011;61(2):69–90.
2.
Glimelius B,
Påhlman L,
Cervantes A.
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis,
treatment and follow-up.
Ann Oncol.
2010 May 1;21(suppl 5):v82–6.
3.
Kang H,
O’Connell JB,
Leonardi MJ,
Maggard MA,
McGory ML,
Ko CY.
Rare tumors of the colon and rectum: a national review.
Int J Colorectal Dis.
2007 Feb;22(2):183–9.
4.
Compton CC.
Colorectal carcinoma: diagnostic,
prognostic,
and molecular features.
Mod Pathol Off J U S Can Acad Pathol Inc.
2003 Apr;16(4):376–88.
5.
Heald RJ,
Ryall RD.
Recurrence and survival after total mesorectal excision for rectal cancer.
Lancet.
1986 Jun 28;1(8496):1479–82.
6.
Adam I.,
Martin I.,
Finan P,
Johnston D,
Mohamdee M.,
Scott N,
et al.
Role of circumferential margin involvement in the local recurrence of rectal cancer.
The Lancet.
1994 Sep;344(8924):707–11.
7.
Heald RJ,
Moran BJ,
Ryall RD,
Sexton R,
MacFarlane JK.
Rectal cancer: the Basingstoke experience of total mesorectal excision,
1978-1997.
Arch Surg Chic Ill 1960.
1998 Aug;133(8):894–9.
8.
Arumugam PJ,
Vivek V,
Carr ND,
Beynon J.
Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer (Br J Surg 2002; 89: 327–34).
Br J Surg.
2002;89(8):1067–1067.
9.
AJCC Cancer Staging Atlas - A Companion to the Seventh Editions of the AJCC Cancer Staging Manual [Internet].
[cited 2015 Jan 5].
Available from: http://www.springer.com/medicine/oncology/book/978-1-4614-2079-8
10.
Valentini V,
Glimelius B,
Haustermans K,
Marijnen CAM,
Rödel C,
Gambacorta MA,
et al.
EURECCA consensus conference highlights about rectal cancer clinical management: the radiation oncologist’s expert review.
Radiother Oncol J Eur Soc Ther Radiol Oncol.
2014 Jan;110(1):195–8.
11.
Kimmey MB,
Martin RW,
Haggitt RC,
Wang KY,
Franklin DW,
Silverstein FE.
Histologic correlates of gastrointestinal ultrasound images.
Gastroenterology.
1989 Feb;96(2 Pt 1):433–41.
12.
Schwartz DA,
Harewood GC,
Wiersema MJ.
EUS for rectal disease.
Gastrointest Endosc.
2002 Jul 1;56(1):100–9.
13.
Nielsen MB,
Hauge C,
Rasmussen OO,
Sørensen M,
Pedersen JF,
Christiansen J.
Anal sphincter size measured by endosonography in healthy volunteers.
Effect of age,
sex,
and parity.
Acta Radiol Stockh Swed 1987.
1992 Sep;33(5):453–6.
14.
Hulsmans FJ,
Tio TL,
Fockens P,
Bosma A,
Tytgat GN.
Assessment of tumor infiltration depth in rectal cancer with transrectal sonography: caution is necessary.
Radiology.
1994 Mar;190(3):715–20.
15.
Beynon J,
Foy DM,
Temple LN,
Channer JL,
Virjee J,
Mortensen NJ.
The endosonic appearances of normal colon and rectum.
Dis Colon Rectum.
1986 Dec;29(12):810–3.
16.
Bhutani MS.
Recent developments in the role of endoscopic ultrasonography in diseases of the colon and rectum.
Curr Opin Gastroenterol.
2007 Jan;23(1):67–73.
17.
Muthusamy VR,
Chang KJ.
Optimal methods for staging rectal cancer.
Clin Cancer Res Off J Am Assoc Cancer Res.
2007 Nov 15;13(22 Pt 2):6877s – 84s.
18.
Vliegen RFA,
Beets GL,
von Meyenfeldt MF,
Kessels AGH,
Lemaire EEMT,
van Engelshoven JMA,
et al.
Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful? Radiology.
2005 Jan;234(1):179–88.
19.
Brown G,
Daniels IR,
Richardson C,
Revell P,
Peppercorn D,
Bourne M.
Techniques and trouble-shooting in high spatial resolution thin slice MRI for rectal cancer.
Br J Radiol.
2005 Mar;78(927):245–51.
20.
Koh D-M,
Collins DJ.
Diffusion-weighted MRI in the body: applications and challenges in oncology.
AJR Am J Roentgenol.
2007 Jun;188(6):1622–35.
21.
Thoeny HC,
Ross BD.
Predicting and monitoring cancer treatment response with diffusion-weighted MRI.
J Magn Reson Imaging JMRI.
2010 Jul;32(1):2–16.
22.
Jung SH,
Heo SH,
Kim JW,
Jeong YY,
Shin SS,
Soung M-G,
et al.
Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging.
J Magn Reson Imaging JMRI.
2012 Jan;35(1):110–6.
23.
Heijnen LA,
Lambregts DMJ,
Mondal D,
Martens MH,
Riedl RG,
Beets GL,
et al.
Diffusion-weighted MR imaging in primary rectal cancer staging demonstrates but does not characterise lymph nodes.
Eur Radiol.
2013 Dec;23(12):3354–60.
24.
Iafrate F,
Laghi A,
Paolantonio P,
Rengo M,
Mercantini P,
Ferri M,
et al.
Preoperative staging of rectal cancer with MR Imaging: correlation with surgical and histopathologic findings.
Radiogr Rev Publ Radiol Soc N Am Inc.
2006 Jun;26(3):701–14.
25.
Beets-Tan RG,
Beets GL,
van der Hoop AG,
Borstlap AC,
van Boven H,
Rongen MJ,
et al.
High-resolution magnetic resonance imaging of the anorectal region without an endocoil.
Abdom Imaging.
1999 Dec;24(6):576–81; discussion 582–4.
26.
Brown G,
Radcliffe AG,
Newcombe RG,
Dallimore NS,
Bourne MW,
Williams GT.
Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging.
Br J Surg.
2003 Mar;90(3):355–64.
27.
Taylor FGM,
Swift RI,
Blomqvist L,
Brown G.
A systematic approach to the interpretation of preoperative staging MRI for rectal cancer.
AJR Am J Roentgenol.
2008 Dec;191(6):1827–35.
28.
MERCURY Study Group.
Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study.
Radiology.
2007 Apr;243(1):132–9.
29.
Kim JH,
Beets GL,
Kim M-J,
Kessels AGH,
Beets-Tan RGH.
High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol.
2004 Oct;52(1):78–83.
30.
Brown G,
Richards CJ,
Bourne MW,
Newcombe RG,
Radcliffe AG,
Dallimore NS,
et al.
Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison.
Radiology.
2003 May;227(2):371–7.
31.
Kaur H,
Choi H,
You YN,
Rauch GM,
Jensen CT,
Hou P,
et al.
MR imaging for preoperative evaluation of primary rectal cancer: practical considerations.
Radiogr Rev Publ Radiol Soc N Am Inc.
2012 Apr;32(2):389–409.
32.
Beets-Tan RG,
Beets GL,
Borstlap AC,
Oei TK,
Teune TM,
von Meyenfeldt MF,
et al.
Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI? Abdom Imaging.
2000 Oct;25(5):533–41.
33.
Gazelle GS,
Gaa J,
Saini S,
Shellito P.
Staging of colon carcinoma using water enema CT.
J Comput Assist Tomogr.
1995 Feb;19(1):87–91.
34.
Horton KM,
Abrams RA,
Fishman EK.
Spiral CT of colon cancer: imaging features and role in management.
Radiogr Rev Publ Radiol Soc N Am Inc.
2000 Apr;20(2):419–30.
35.
Calvo FA,
Domper M,
Matute R,
Martínez-Lázaro R,
Arranz JA,
Desco M,
et al.
18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation.
Int J Radiat Oncol Biol Phys.
2004 Feb 1;58(2):528–35.
36.
Shin SS,
Jeong YY,
Min JJ,
Kim HR,
Chung TW,
Kang HK.
Preoperative staging of colorectal cancer: CT vs.
integrated FDG PET/CT.
Abdom Imaging.
2008 Jun;33(3):270–7.
37.
Berger KL,
Nicholson SA,
Dehdashti F,
Siegel BA.
FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features.
AJR Am J Roentgenol.
2000 Apr;174(4):1005–8.
38.
Kinkel K,
Lu Y,
Both M,
Warren RS,
Thoeni RF.
Detection of Hepatic Metastases from Cancers of the Gastrointestinal Tract by Using Noninvasive Imaging Methods (US,
CT,
MR Imaging,
PET): A Meta-Analysis.
Radiology.
2002 Sep 1;224(3):748–56.